PROVIDENCE – The R.I. Executive Office of Health & Human Services received $1.5 million from the settlement of allegations Mylan Inc. and Mylan Specialty LP knowingly underpaid rebates owed to the Medicaid program for the drugs EpiPen and EpiPen Jr. dispensed to Medicaid beneficiaries. The settlement, announced Nov. 17, resolves allegations that from July 29,…
This article is available only to PBN Subscribers. To get unlimited access, please subscribe by following the link below.
Already a subscriber? Login now
Want to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.